Luis Alexis Hernández-Palma

Dr. Luis Alexis Hernández-Palma

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Cytokine
Verified
Journal Article
Closed access
LHLuis Alexis Hernández-Palma
Luis Alexis Hernández-Palma
SGSamuel García-Arellano
Samuel García-Arellano
RBRichard Bucala
Richard Bucala
MLMara Anaís Llamas-Covarrubias
Mara Anaís Llamas-Covarrubias
Ulises De la Cruz-MossoUlises De la Cruz-Mosso
Ulises De la Cruz-Mosso
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle

Verified
Journal Article
Open access
PDF file
AGAna M González-Martin
Ana M González-Martin
E. Samid Limon-VillegasE. Samid Limon-Villegas
E. Samid Limon-Villegas
ZRZyanya Reyes-Castillo
Zyanya Reyes-Castillo
FEFrancisco Esparza-Ros
Francisco Esparza-Ros
LHLuis Alexis Hernández-Palma
Luis Alexis Hernández-Palma
Nicoletta RighiniNicoletta Righini
Nicoletta Righini
Background: Sarcopenia is a progressive muscle disease that compromises mobility and quality of life in older adults. Although dual-energy X-ray absorptiometry (DXA) is the standard for assessing Appendicular Lean Mass Index (ALMI), it is costly and often inaccessible. This study aims to develop machine learning models using anthropometric measurements to predict low ALMI for the diagnosis of sarcopenia. Methods: A cross-sectional study was conducted on 183 Mexican adults (67.2% women and 32.8% men, ≥60 years old). ALMI was measured using DXA, and anthropometric data were collected following the International Society for the Advancement of Kinanthropometry (ISAK) protocols. Predictive models were developed using Logistic Regression (LR), Decision Trees (DTs), Random Forests (RFs), Artificial Neural Networks (ANNs), and LASSO regression. The dataset was split into training (70%) and testing (30%) sets. Model performance was evaluated using classification performance metrics and the area under the ROC curve (AUC). Results: ALMI indicated strong correlations with BMI, corrected calf girth, and arm relaxed girth. Among models, DT achieved the best performance in females (AUC = 0.84), and ANN indicated the highest AUC in males (0.92). Regarding the prediction of low ALMI, specificity values were highest in DT for females (100%), while RF performed best in males (92%). The key predictive variables varied depending on sex, with BMI and calf girth being the most relevant for females and arm girth for males. Conclusions: Anthropometry combined with machine learning provides an accurate, low-cost approach for identifying low ALMI in older adults. This method could facilitate sarcopenia screening in clinical settings with limited access to advanced diagnostic tools.

21 October 2023 in Endocrine Research
Verified
Journal Article
Closed access
AVAna B. Vargas-Antillón
Ana B. Vargas-Antillón
MPMildren Porchas-Quijada
Mildren Porchas-Quijada
EZEloy A. Zepeda-Carrillo
Eloy A. Zepeda-Carrillo
RTRafael Torres-Valadez
Rafael Torres-Valadez
José Francisco Muñoz-ValleJosé Francisco Muñoz-Valle
José Francisco Muñoz-Valle
ZRZyanya Reyes-Castillo
Zyanya Reyes-Castillo
Background and aims: Patients with obesity and type 2 diabetes (T2D) have shown alterations in the affinity of IgG anti-leptin antibodies which are possibly related to metabolic alterations. In the present exploratory study, we analyzed serum samples from adults with T2D classified by body mass index (BMI) and evaluated the relationship of IgG anti-leptin antibodies with body composition, metabolic and cardiovascular risk parameters.Methods: Serum IgG anti-leptin antibodies (total, free and immune complexes fractions) were measured by in-house ELISA. Body composition, metabolic biomarkers (glucose, glycated hemoglobin, lipid profile, insulin, leptin) and cardiometabolic risk indexes (AIP, HOMA-IR, HOMA-ss) were evaluated in one hundred T2D patients.Results: Patients with T2D and obesity presented a decrease in the percentage of IgG anti-leptin immune complexes compared to patients with T2D and overweight (p < 0.0053). Negative correlations of IgG anti-leptin immune complexes with triglycerides (TG) (r=-0.412, p = 0.023) and VLDL-C (r=-0.611, p = 0.017) were found in normal weight T2D patients. Free IgG anti-leptin antibodies correlated positively with TC (r = 0.390, p = 0.032) and LDL-C (r = 0.458, p = 0.011) in overweight individuals with T2D. Finally, total IgG anti-leptin antibodies correlated positively with leptin hormone levels (r = 0.409, p = 0.024) and negatively with HOMA-IR (r =-0.459, p = 0.012) in T2D patients with obesity.Conclusions: The decrease of IgG anti-leptin immune complexes observed in patients with T2D and obesity suggests a reduction in antibody affinity to the hormone that may impact its transport and signaling, lipid, lipoprotein and insulin metabolism.